Up | AC
Home Page
Food and
Drug Administration
oint
Meeting of the Anesthetic and Life Support Drugs Advisory Committee and
Drug Safety
& Risk Management Advisory Committee
January
30, 2009
FDA
Disclaimer
Portions
of this document have been determined to be exempt from disclosure under the
Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA
Briefing Material (pdf)
Xanodyne Pharmaceuticals, Inc. & Qualitest/Vintage
Pharmaceuticals
Disclaimer
The
statements contained in this document(s) are those of the product's sponsors,
not FDA, and FDA does not necessarily agree with the sponsors’ statements. FDA
has not made a final determination about the safety or effectiveness of the
product described in this document.
Briefing Material (pdf)